Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Recruiting 3Active not recruiting 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Ovarian Neoplasms 35Breast Neoplasms 32Lung Neoplasms 28Uterine Cervical Neoplasms 18Triple Negative Breast Neoplasms 15Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Small Cell Lung Carcinoma 13Squamous Cell Carcinoma of Head and Neck 10Neuroblastoma 10Esophageal Neoplasms 10Esophageal Squamous Cell Carcinoma 8Central Nervous System Neoplasms 8Recurrence 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Retinoblastoma 5Neoplasm Metastasis 5Brain Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 4Melanoma 4Carcinoma, Squamous Cell 4Testicular Neoplasms 3Oligodendroglioma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Glioblastoma 3

Interventions

Cisplatin 4tremelimumab 3Pemetrexed 3durvalumab 2atezolizumab 2Radiotherapy 2Nivolumab 2Mitomycin 2Doxorubicin 2toripalimab 1talazoparib 1rucaparib 1regorafenib 1ranpirnase 1pembrolizumab 1niraparib 1liposomal doxorubicin 1dostarlimab 1cemiplimab 1bemcentinib 1avelumab 1abemaciclib 1Vinorelbine 1Vinblastine 1Thiostrepton 1Surgical Procedures, Operative 1Oxaliplatin 1One-Lung Ventilation 1Neoadjuvant Therapy 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mesothelioma, Malignant × Carboplatin × Clear all
NCT04713761 2021-01-26

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
15 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡